课题基金 / 基金详情

NW Research Center for Excellence in Biodefense and Emerging Infectious Diseases

NW Research Center for Excellence in Biodefense and Emerging Infectious Diseases
西北生物防御和新发传染病卓越研究中心
批准号:
8447080
负责人:
Samuel I Miller
金额:
$737.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-04 至 2015-02-28

项目摘要

项目成果

Samuel I Miller的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Region X Northwest Regional Center of Excellence (NWRCE) for Biodefense and Emerging Infectious Diseases is an essential component in a nationwide network of biomedical research programs to combat infectious disease threats to the population. The NWRCE is currently a highly interactive and thematic program focused on Gram-negative bacterial pathogens, and the same general consistent focus has existed since its inception. There are three research themes: (1) mechanisms of Gram-negative bacterial pathogenesis, (2) innate immune responses to Gram-negative bacterial pathogens, and (3) translation of (1) and (2) into early stage therapeutic development to prevent or treat Gram-negative bacterial diseases. The NWRCE is centered at the University of Washington (UW) in Seattle; in this renewal application, multiple sites are proposed in Seattle, two in Oregon, one in Idaho, and one in Maryland. Additional sites for collaboration include the NIAID Rocky Mountain Laboratory in Montana, the University of Victoria, British Columbia, and collaborators at sites in Thailand, Sweden, and Mexico. The projects, cores, domestic and international sites, as well as collaborators, are highly interactive. The individuals that make up this proposal have worked together for many years during the last funding period and before the NWRCE was created. The majority of investigators newly added to this to this application for renewed funding of the NWRCE have had long collaborative relationships with members of the center. The interactive nature and focus of the NWRCE is a major strength of the program and allows the NWRCE to rapidly and nimbly respond to national priorities to achieve important objectives with respect to Gram-negative bacterial infections.
期刊论文(108)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1128/mbio.00499-12
发表时间: 2012-12-18
期刊: mBio
影响因子: 6.4
作者: [Chandler JR, Truong TT, Silva PM, Seyedsayamdost MR, Carr G, Radey M, Jacobs MA, Sims EH, Clardy J, Greenberg EP]
通讯作者: Greenberg EP
Cutting edge: Genetic variation in TLR1 is associated with Pam3CSK4-induced effector T cell resistance to regulatory T cell suppression.
最前沿:TLR1 的遗传变异与 Pam3CSK4 诱导的效应 T 细胞对调节性 T 细胞抑制的抵抗力相关。
DOI: 10.4049/jimmunol.1401185
发表时间: 2014
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Mikacenic,Carmen, Schneider,Anya, Radella,Frank, Buckner,JaneH, Wurfel,MarkM]
通讯作者: Wurfel,MarkM
DOI: 10.7554/elife.01402
发表时间: 2013-12-17
期刊: eLife
影响因子: 7.7
作者: [Kulasekara BR, Kamischke C, Kulasekara HD, Christen M, Wiggins PA, Miller SI]
通讯作者: Miller SI
DOI: 10.1021/ac103079q
发表时间: 2011-03-15
期刊: ANALYTICAL CHEMISTRY
影响因子: 7.4
作者: [Panchaud, Alexandre, Jung, Sunhee, Shaffer, Scott A., Aitchison, John D., Goodlett, David R.]
通讯作者: Goodlett, David R.
55
    Salmonella pathogenicity island 2 effector proteins
    • 批准号:
      9526598
    • 项目类别:
    • 资助金额:
      $38.76万
    • 财政年份:
      2017
    • 负责人:
      Samuel I Miller
    • 依托单位:
    Funtion of Uncharacterized Genes of Acinetobacter baumanii
    • 批准号:
      8581005
    • 项目类别:
    • 资助金额:
      $144.39万
    • 财政年份:
      2013
    • 负责人:
      Samuel I Miller
    • 依托单位:
    Funtion of Uncharacterized Genes of Acinetobacter baumanii
    • 批准号:
      9282562
    • 项目类别:
    • 资助金额:
      $146.37万
    • 财政年份:
      2013
    • 负责人:
      Samuel I Miller
    • 依托单位:
    Administrative Core
    • 批准号:
      8597721
    • 项目类别:
    • 资助金额:
      $8.9万
    • 财政年份:
      2013
    • 负责人:
      Samuel I Miller
    • 依托单位:
    海外基金